Benign Tumor Clinical Trials

• A-Protein Levels in Adult and Pediatric Brain Tumor Patients
  ClinicalTrials.gov Identifier: NCT00165542 - Active, not recruiting
  Malignant or Benign Lesions of the Central Nervous System
  
• rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter.
  ClinicalTrials.gov Identifier: NCT00145366 - Active, not recruiting
  Benign nontoxic and toxic goiter; Graves'' disease
  
• A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00127179 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
  ClinicalTrials.gov Identifier: NCT00003590 - Active, not recruiting
  recurrent adult brain tumor; grade I meningioma
  
• Benign Prostatic Hyperplasia Trial With Avodart And Tamsulosin Combination Treatment
  ClinicalTrials.gov Identifier: NCT00090103 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00384930 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
  ClinicalTrials.gov Identifier: NCT00316732 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter.
  ClinicalTrials.gov Identifier: NCT00275171 - Recruiting
  Benign Nontoxic Nodular Goitre
  
• Laser Therapy of Benign Thyroid Nodules
  ClinicalTrials.gov Identifier: NCT00150150 - Active, not recruiting
  Benign solitary solid; cystic thyroid nodules
  
• Kinetics of the Finasteride Prostate Induced Apoptosis
  ClinicalTrials.gov Identifier: NCT00130767 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
  ClinicalTrials.gov Identifier: NCT00368979 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Vardenafil In Benign Prostate Hypertrophy
  ClinicalTrials.gov Identifier: NCT00461123 - Recruiting
  Benign Prostate Hyperplasia (BPH)
  
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00284518 - Recruiting
  Benign Prostatic Hyperplasia
  
• Randomized, Double Blinded, Trial of Pomegranate Tabs vs Placebo-Effects on Symptoms of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00381108 - Recruiting
  Benign Prostatic Hyperplasia
  
• Multi-Carotenoids in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00501371 - Recruiting
  Benign Prostatic Hyperplasia
  
• Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia in Asian Men
  ClinicalTrials.gov Identifier: NCT00540124 - Recruiting
  Benign Prostatic Hyperplasia
  
• Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00386009 - Recruiting
  Benign Prostatic Hyperplasia
  
• A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
  ClinicalTrials.gov Identifier: NCT00465101 - Recruiting
  Benign Prostatic Hyperplasia
  
• Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
  ClinicalTrials.gov Identifier: NCT00449150 - Recruiting
  Benign Prostatic Hypertrophy
  
• PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
  ClinicalTrials.gov Identifier: NCT00407953 - Recruiting
  Benign Prostatic Hyperplasia (BPH)
  
• Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
  ClinicalTrials.gov Identifier: NCT00069940 - Active, not recruiting
  Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer
  
• Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
  ClinicalTrials.gov Identifier: NCT00005955 - Active, not recruiting
  childhood brain tumor; childhood nerve tumor
  
• Study of SU011248 in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00056693 - Active, not recruiting
  Neuroendocrine Tumor; Carcinoid Tumor
  
• Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
  ClinicalTrials.gov Identifier: NCT00005790 - Active, not recruiting
  genetic condition; Cancer; adult brain tumor; Brain Tumor; stage/type, adult brain tumor; body system/site cancer; central nervous system cancer; ...
  
• Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
  ClinicalTrials.gov Identifier: NCT00230217 - Active, not recruiting
  Tumors; Hyperuricemia; Tumor Lysis Syndrome
  
• Study of Rasburicase Versus Allopurinol in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome
  ClinicalTrials.gov Identifier: NCT00230178 - Active, not recruiting
  Tumor Lysis Syndrome; Cancer; Hyperuricemia
  
• Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
  ClinicalTrials.gov Identifier: NCT00006342 - Active, not recruiting
  Lymphoma; Brain Tumor
  
• Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
  ClinicalTrials.gov Identifier: NCT00527605 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• Comparing Synthetic Bone Alone Versus Synthetic Bone with Bone Marrow in Bone Lesions
  ClinicalTrials.gov Identifier: NCT00147823 - Recruiting
  Benign bone lesion
  
• Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
  ClinicalTrials.gov Identifier: NCT00003804 - Active, not recruiting
  stage I Wilms' tumor
  
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008086 - Active, not recruiting
  Brain Tumor; Genetic Condition; Solid Tumor
  
• FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00084461 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Bevacizumab in Combination with Temozolomide in Patients with Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00137774 - Active, not recruiting
  Metastatic Neuroendocrine Tumor; Neuroendocrine Tumor
  
• Photoselective Vaporization of the Prostate Compared to Transurethral Resection of the Prostate for the Treatment of Benign Hyperplasia of the Prostate
  ClinicalTrials.gov Identifier: NCT00527371 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00027638 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00093782 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)
  ClinicalTrials.gov Identifier: NCT00199550 - Active, not recruiting
  BPH; Benign Prostatatic Hyperplasia
  
• A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.
  ClinicalTrials.gov Identifier: NCT00379067 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003852 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; pediatric germ cell tumor; extragonadal germ cell tumor
  
• Tumor Cell Vaccine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002505 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00009906 - Active, not recruiting
  gastrointestinal stromal tumor
  
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
  ClinicalTrials.gov Identifier: NCT00019565 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• A Pilot Study of Tumor Cell Vaccine for High-Risk Solid Tumor Patients Following Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00405327 - Recruiting
  Sarcoma; Neuroblastoma; Wilm's Tumor
  
• Study Of Su011248 Administered In A Daily Regimen In Patients With Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00137449 - Active, not recruiting
  Gastrointestinal Stromal Tumor
  
• Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH
  ClinicalTrials.gov Identifier: NCT00347061 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
  ClinicalTrials.gov Identifier: NCT00014573 - Active, not recruiting
  Brain Tumor
  
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00002472 - Active, not recruiting
  childhood central nervous system germ cell tumor; extragonadal germ cell tumor; adult central nervous system germ cell tumor; ...
  
• Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002508 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; extragonadal germ cell tumor
  
• Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00215501 - Active, not recruiting
  Solid Tumor
  
• Tariquidar Plus Chemotherapy in Treating Children With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00020514 - Active, not recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00005796 - Active, not recruiting
  Brain Tumor
  
• Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00251407 - Active, not recruiting
  Solid Tumor
  
• The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
  ClinicalTrials.gov Identifier: NCT00427219 - Active, not recruiting
  Benign Prostatic Hypertrophy
  
• SU011248 in Treating Patients With Malignant Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00085618 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
  Central Nervous System Tumor; Brain Tumor
  
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416767 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00021385 - Active, not recruiting
  recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; stage IV ovarian germ cell tumor; ...
  
• Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003811 - Active, not recruiting
  childhood malignant testicular germ cell tumor; childhood mature and immature teratomas; Drug Toxicity; recurrent childhood malignant germ cell tumor; ...
  
• Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
  ClinicalTrials.gov Identifier: NCT00047138 - Recruiting
  Wilms' Tumor; Wilms' tumor and other childhood kidney tumors
  
• Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00025246 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00041197 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Stereotactic Radiosurgery in Treating Patients With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00019578 - Active, not recruiting
  Adult Central Nervous System Germ Cell Tumor; Adult Malignant Meningioma; Adult Medulloblastoma; Adult Noninfiltrating Astrocytoma; Adult Oligodendroglioma; Adult Craniopharyngioma; Adult Meningioma; Brain Metastases; Adult Ependymoma; Adult Pineal Parenchymal Tumor; Adult Brain Stem Glioma; Adult Infiltrating Astrocytoma; Mixed Gliomas; Stage IV Peripheral Primitive Neuroectodermal Tumor
  
• Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
  ClinicalTrials.gov Identifier: NCT00274417 - Active, not recruiting
  Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
  
• Antineoplaston Therapy in Treating Patients With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003457 - Recruiting
  ACTH-producing pituitary tumor; TSH producing pituitary tumor; adult brain tumor
  
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
  ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
  
• Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00466856 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Metastatic Cancer; Neoplastic Syndrome; Pheochromocytoma
  
• Laser Prostatectomy Database and Registry
  ClinicalTrials.gov Identifier: NCT00159406 - Recruiting
  BPH; Benign Prostatic Hyperplasia; Enlarged Prostate
  
• Sorafenib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00131911 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
  ClinicalTrials.gov Identifier: NCT00499317 - Recruiting
  Chronic Prostatitis (CP); Chronic Pelvic Pain Syndrome (CPPS); Painful Bladder Syndrome (PBS); Benign Frequency Syndrome (BFS); Benign Daytime Frequency Syndrome (BDFS)
  
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00075439 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Levetiracetam for Benign Rolandic Epilepsy
  ClinicalTrials.gov Identifier: NCT00181116 - Active, not recruiting
  Epilepsy
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Optical Clearing of the Skin in Conjunction With Laser Treatments
  ClinicalTrials.gov Identifier: NCT00580736 - Enrolling by invitation
  Port Wine Stain; Benign Vascular Lesion; Nevus of Ota; Tattoos; Scars; Acne; Hypertrichosis; Sebaceous Hyperplasia
  
• CCI-779 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003712 - Active, not recruiting
  recurrent adult brain tumor; unspecified adult solid tumor, protocol specific; brain metastases
  
• MEN-10755 in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003982 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; testicular embryonal carcinoma and yolk sac tumor
  
• Rasburicase in Treating or Preventing High Levels of Uric Acid in the Blood and Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00086918 - Active, not recruiting
  Cancer; hyperuricemia; Tumor Lysis Syndrome
  
• Preoperative Assessment of Colon Tumor
  ClinicalTrials.gov Identifier: NCT00114829 - Recruiting
  Colorectal Cancer; Colorectal Tumor
  
• Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
  ClinicalTrials.gov Identifier: NCT00023790 - Active, not recruiting
  adult solid tumor; Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; skin tumor
  
• Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor
  ClinicalTrials.gov Identifier: NCT00262327 - Active, not recruiting
  Advanced Solid Tumor
  
• Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
  ClinicalTrials.gov Identifier: NCT00003702 - Active, not recruiting
  Hydatidiform Mole; uterine choriocarcinoma; nonmetastatic gestational trophoblastic tumor; good prognosis metastatic gestational trophoblastic tumor
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049023 - Recruiting
  Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma
  
• Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00416390 - Active, not recruiting
  Precancerous/Nonmalignant Condition; Prostate Cancer
  
• NGR-TNF in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00098943 - Active, not recruiting
  adult solid tumor; Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; kidney and urinary cancer
  
• Safety and Effectiveness of Combretastatin A-4 Phosphate Combined with Chemotherapy in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00113438 - Active, not recruiting
  Cancer; Tumor
  
• Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor
  ClinicalTrials.gov Identifier: NCT00003755 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Drugs to Reduce the Side Effects of Chemotherapy
  ClinicalTrials.gov Identifier: NCT00003213 - Active, not recruiting
  solid tumor; Nausea; Vomiting
  
• Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision
  ClinicalTrials.gov Identifier: NCT00575354 - Completed
  Breast Neoplasms
  
• Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00399464 - Active, not recruiting
  Prostatic Hyperplasia
  
• Safety and Efficacy Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone
  ClinicalTrials.gov Identifier: NCT00396279 - Active, not recruiting
  GCT; Giant Cell Tumor of Bone
  
• SAMBA-Thailand: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
  ClinicalTrials.gov Identifier: NCT00401661 - Active, not recruiting
  Prostatic Hyperplasia
  
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
  adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
  
• Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00467051 - Recruiting
  Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
  ClinicalTrials.gov Identifier: NCT00400894 - Active, not recruiting
  Prostate Cancer; Benign Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia
  
• SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
  ClinicalTrials.gov Identifier: NCT00486785 - Active, not recruiting
  Prostatic Hyperplasia
  
• Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00028002 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Development of the MDASI-Spine Tumor Module
  ClinicalTrials.gov Identifier: NCT00430872 - Recruiting
  Spinal Cord Tumor
  
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00536601 - Recruiting
  Childhood Germ Cell Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Neuroblastoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00407329 - Recruiting
  BPH